Zhenghai Biotech announced on December 15 that the company recently signed a “Technology Development Contract” with the trustee, the Institute of Biotechnology of the Chinese Academy of Agricultural Sciences, for the “Research and Development of Recombinant Type III Collagen Products” project, with a total contract amount of 12 million yuan. The company will rely on this collaboration to develop medical products using recombinant collagen as a raw material and build a multi-dimensional product matrix.

Zhenghai Biotech announced on December 15 that the company recently signed a “Technology Development Contract” with the trustee, the Institute of Biotechnology of the Chinese Academy of Agricultural Sciences, for the “Research and Development of Recombinant Type III Collagen Products” project, with a total contract amount of 12 million yuan. The company will rely on this collaboration to develop medical products using recombinant collagen as a raw material and build a multi-dimensional product matrix.